The Entrepreneur'sRESOURCE

Explore the Resource Center to find resources.  Designed with entrepreneurs in mind, our resource center allows you to find materials to grow great ideas.

When the patients met the innovators at MedCity CONVERGE

Christina Hernandez Sherwood, eMed Editor, MedCity News

At MedCity CONVERGE, a national, executive-level summit on healthcare innovation in Philadelphia last week, local AARP members were on hand to learn about the two-dozen companies represented in the Pfizer Startup Showcase.

When asked which startups they believed would help solve today's health problems, AARP members singled out the following companies:

Quick: A biomedical mobile application company specializing in diagnostic and measuring products that incorporate smart devices. Quick is creating noninvasive personal testing platforms that are painless, bloodless, and mobile. Quick's most strategic area of focus is monitoring patients with diabetes.

Vimty: An online tool to help patients and their families understand, collaborate, and make decisions for the last stages of their lives. Vimty simplifies both the topic and the process, enabling members to make decisions as well as create, notarize and store the digital advanced directive all in one sitting.

Neurotrack: This technology can diagnose Alzheimer's disease three to six years before symptoms appear, creating the potential to transform diagnosis and treatment. Based on research and tested during a six-year longitudinal study, Neurotrack's computer-based cognitive/visual test gives pharmaceutical companies and research organizations the tools to recruit truly qualified candidates for clinical trials and more effectively measure drug efficacy, speeding up drug discovery and development.

The full video is available below:

Related on eMed:

comments powered by Disqus

Search for Resources

Stay Connected

Email Newsletter Signup

Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.

Email Newsletters

Want to be up-to-date with the latest news and updates from To subscribe, just give us your email address below; you'll choose which e-newsletters you'd like to receive on the next screen.